Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewGenIvf (NIVF) Notes Payables (2024 - 2025)

NewGenIvf (NIVF) has disclosed Notes Payables for 2 consecutive years, with $256056.0 as the latest value for Q4 2025.

  • Quarterly Notes Payables rose 210.57% to $256056.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $256056.0 through Dec 2025, up 210.57% year-over-year, with the annual reading at $256056.0 for FY2025, 210.57% up from the prior year.
  • Notes Payables for Q4 2025 was $256056.0 at NewGenIvf, up from $82447.0 in the prior quarter.
  • The five-year high for Notes Payables was $256056.0 in Q4 2025, with the low at $82447.0 in Q4 2024.